See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2015_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 24,904,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 40,000 |
| 2 | PropertyPlantAndEquipmentNet | 481,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 1,616,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,014,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,848,626 |
| 9 | ResearchAndDevelopmentExpense | 14,203,763 |
| 10 | remainder_Expenses | -523,167 |
| 11 | remainder_Revenues | 47,313 |
| 12 | remainder_NetIncome | 3,402,801 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,425,000 |
| 1 | Liabilities | 2,630,000 |
| 2 | Expenses | 19,529,222 |
| 3 | Revenues | 47,313 |
| 4 | StockholdersEquity | 22,795,000 |
| 5 | NetIncome | -16,079,108 |
| 6 | ComprehensiveNetIncome | -16,079,108 |
| 7 | BaseVar | 25,517,168 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.40 |
| 9 | EconomicCapitalRatio | 3.29 |